[(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

C30H37NO5 — CID 71615449

IUPAC[(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](C(=O)/C=C/c5ccc([N+](=O)[O-])cc5)[C@@]4(C)CC[C@@H]32)C1
InChIInChI=1S/C30H37NO5/c1-19(32)36-23-14-16-29(2)21(18-23)7-10-24-25-11-12-27(30(25,3)17-15-26(24)29)28(33)13-6-20-4-8-22(9-5-20)31(34)35/h4-9,13,23-27H,10-12,14-18H2,1-3H3/b13-6+/t23-,24-,25-,26-,27+,29-,30-/m0/s1
InChIKeyCDZJNMZJLYLTJO-WVCVZXOZSA-N
MW491.63 g/mol
LogP6.69
Rot. Bonds5

About [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

[(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (PubChem CID 71615449) has the molecular formula C30H37NO5 and a molecular weight of 491.63 g/mol. Its IUPAC name is [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.

Molecular Properties

Compound Name[(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
PubChem CID71615449
Molecular FormulaC30H37NO5
Molecular Weight491.63 g/mol
Exact Mass491.27
IUPAC Name[(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](C(=O)/C=C/c5ccc([N+](=O)[O-])cc5)[C@@]4(C)CC[C@@H]32)C1
InChIInChI=1S/C30H37NO5/c1-19(32)36-23-14-16-29(2)21(18-23)7-10-24-25-11-12-27(30(25,3)17-15-26(24)29)28(33)13-6-20-4-8-22(9-5-20)31(34)35/h4-9,13,23-27H,10-12,14-18H2,1-3H3/b13-6+/t23-,24-,25-,26-,27+,29-,30-/m0/s1
InChIKeyCDZJNMZJLYLTJO-WVCVZXOZSA-N
XLogP6.69
TPSA86.51 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500491.63
LogP ≤ 56.69
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The IUPAC name of [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (CID 71615449) is [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.
What is the SMILES notation for [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The canonical SMILES for [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate is CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](C(=O)/C=C/c5ccc([N+](=O)[O-])cc5)[C@@]4(C)CC[C@@H]32)C1.
What is the InChIKey of [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The InChIKey is CDZJNMZJLYLTJO-WVCVZXOZSA-N. The full InChI is InChI=1S/C30H37NO5/c1-19(32)36-23-14-16-29(2)21(18-23)7-10-24-25-11-12-27(30(25,3)17-15-26(24)29)28(33)13-6-20-4-8-22(9-5-20)31(34)35/h4-9,13,23-27H,10-12,14-18H2,1-3H3/b13-6+/t23-,24-,25-,26-,27+,29-,30-/m0/s1.
What are the key properties of [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
[(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate has a molecular weight of 491.63 g/mol, XLogP of 6.69, 5 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,8S,9S,10R,13S,14S,17S)-10,13-dimethyl-17-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate is sourced from PubChem (CID 71615449), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).